Biogenex Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.99 Cr
as on 16-11-2024
- Satisfied Charges ₹ 37.19 Cr
as on 16-11-2024
- Revenue -1.17%
(FY 2023)
- Profit -113.35%
(FY 2023)
- Ebitda -104.25%
(FY 2023)
- Net Worth -2.32%
(FY 2023)
- Total Assets -0.28%
(FY 2023)
About Biogenex Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹9.99 Cr. The company has closed loans amounting to ₹37.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishan Kalra, Srinath Buragadda, and Veerapaneni Babu serve as directors at the Company.
- CIN/LLPIN
U73100TG2005PTC045566
- Company No.
045566
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biogenex Life Sciences Private Limited offer?
Biogenex Life Sciences Private Limited offers a wide range of products and services, including Electrodiagnostic Instruments, Medical Diagnostic Equipment, Glass Slides.
Who are the key members and board of directors at Biogenex Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishan Kalra  | Managing Director | 16-Aug-2005 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinath Buragadda  | Nominee Director | 21-May-2012 | Current |
| Veerapaneni Babu | Additional Director | 15-Apr-2024 | Current |
Financial Performance of Biogenex Life Sciences.
Biogenex Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.17% decrease. The company also saw a substantial fall in profitability, with a 113.35% decrease in profit. The company's net worth dipped by a decrease of 2.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biogenex Life Sciences?
In 2023, Biogenex Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Omicsveu Precision Oncology Private LimitedActive 6 months 22 daysKrishan Kalra and Veerapaneni Babu are mutual person
- Buragadda Niranjan Rao Health Care Private LimitedActive 8 months 3 days
Srinath Buragadda is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Technology Development Board Creation Date: 02 Dec 2011 | ₹9.99 Cr | Open |
3I Infotech Trusteeship Services Limited Creation Date: 12 Apr 2010 | ₹29.95 Cr | Satisfied |
Union Bank Of India - Secunderabad Branch Creation Date: 30 Jan 2009 | ₹7.24 Cr | Satisfied |
How Many Employees Work at Biogenex Life Sciences?
Biogenex Life Sciences has a workforce of 84 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogenex Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenex Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
